Understand what your gut health results really mean
See your biomarkers in context with a comprehensive panel.
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
Eubacterium rectale: Measuring a major butyrate producer in your gut
The Eubacterium rectale test measures the abundance of Eubacterium rectale in a stool sample. Labs typically analyze microbial DNA using methods like 16S rRNA gene sequencing, shotgun metagenomics, or targeted qPCR to estimate how much of this species is present relative to the rest of your gut community. Results are usually reported as a percentage, percentile, or reads per million, reflecting your current microbiome snapshot rather than a fixed trait. Because taxonomy is evolving, some reports group this organism with closely related butyrate producers or label it within the E. rectale–Roseburia complex; a few databases use updated genus names that can differ by lab.
Why focus on this microbe? Eubacterium rectale is a prominent producer of butyrate, a short‑chain fatty acid that fuels colon cells, strengthens the intestinal barrier, and shapes immune balance. Butyrate supports tight junctions, promotes regulatory T‑cell activity, and helps keep inflammatory signaling in check. In observational research, lower levels of E. rectale and other butyrate producers are often seen with inflammatory bowel conditions and metabolic risk profiles, while fiber‑rich eating patterns tend to correlate with higher levels—though more research is needed to define precise targets for individuals.
Why this one species earns its own test
This test connects a single, well‑studied function of the gut ecosystem—butyrate production—to everyday health questions. If your Eubacterium rectale is low, it can suggest reduced capacity to generate butyrate from fermentable fibers found in foods like beans, oats, and cooked‑and‑cooled grains and potatoes. That may map to symptoms such as stool inconsistency, gas, or gut sensitivity, or to contexts like recent antibiotic use, a very low‑fiber diet, or prolonged stress. If it’s robust, you may have a helpful buffer for barrier integrity and inflammatory tone. Either way, the result doesn’t diagnose a condition; it points to how your gut’s fuel supply for the colon lining is trending right now.
Zooming out, Eubacterium rectale acts like a sentinel for a microbiome that can turn fiber into health‑protective metabolites. Butyrate interacts with glucose regulation, gut–brain signaling, and systemic inflammation, which is why this single marker can be informative beyond digestion. Re‑checking after meaningful changes—like adjusting fiber sources, recovering from antibiotics, or shifting training loads—helps you see if the microbiome is moving in a resilient direction. The aim isn’t a “perfect” number. It’s learning how your gut responds over time so you and your clinician can make grounded, data‑informed decisions.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Test 100+ biomarkers from home
One blood draw. A full picture of your health, explained in plain language.
Putting a Eubacterium rectale number on a mental map
Most reports show your Eubacterium rectale as a relative abundance compared with a reference population. In general, balanced gut ecosystems feature a healthy representation of butyrate producers (including Eubacterium rectale, Faecalibacterium, and certain Roseburia species) alongside overall microbial diversity. A value near or above population medians often aligns with stronger butyrate generation, while a value well below peers can flag limited fermentation of fiber into short‑chain fatty acids. “Normal” ranges vary by lab, geography, and diet patterns, so context matters when interpreting cutoffs.
When this marker looks “optimal” for you, it suggests efficient fiber fermentation, more butyrate available to fuel colon cells, and biological signals consistent with a calmer, more selective immune response. People often experience steadier digestion when butyrate production is adequate, which can translate into less reactivity to routine dietary shifts. There is no universal target—your personal best depends on your overall microbiome, dietary pattern, and life stage.
If Eubacterium rectale is low, that can indicate reduced butyrate capacity, sometimes seen after antibiotics, during prolonged low‑fiber or highly processed eating patterns, or alongside broader dysbiosis. You might also see other signs of imbalance on a comprehensive report, such as lower diversity or higher representation of inflammation‑associated taxa. This is a prompt for exploration rather than a diagnosis. Mechanistically, improving the supply of fermentable substrates can encourage butyrate pathways, and if symptoms persist or systemic markers are abnormal, medical evaluation helps rule out underlying conditions.
Companion reads for a Eubacterium rectale result
Big picture, this single‑species readout is most powerful when paired with other data—stool inflammation markers (e.g., calprotectin), overall microbiome diversity, and systemic labs such as HbA1c or hs‑CRP—to align your gut findings with metabolic and inflammatory status. Interpreting trends across time matters more than any one result. If Eubacterium rectale rises in step with more dietary fiber variety and your digestion steadies, that pattern suggests your microbiome is converting inputs into protective outputs.
Frequently Asked Questions
References
- Mukherjee A, Lordan C, Ross RP, Cotter PD (2020). Gut microbes from the phylogenetically diverse genus Eubacterium and their various contributions to gut health. *Gut Microbes*, *12*(1), 1802866. https://doi.org/10.1080/19490976.2020.1802866
- Parada Venegas D, De la Fuente MK, Landskron G, González MJ, Quera R, Dijkstra G, Harmsen HJM, Faber KN, Hermoso MA (2019). Short chain fatty acids (SCFAs)-mediated gut epithelial and immune regulation and its relevance for inflammatory bowel diseases. *Frontiers in Immunology*, *10*, 277. https://doi.org/10.3389/fimmu.2019.00277
- Paone P, Cani PD (2020). Mucus barrier, mucins and gut microbiota: The expected slimy partners? *Gut*, *69*(12), 2232-2243. https://doi.org/10.1136/gutjnl-2020-322260
- Laudadio I, Fulci V, Palone F, Stronati L, Cucchiara S, Carissimi C (2018). Quantitative assessment of shotgun metagenomics and 16S rDNA amplicon sequencing in the study of human gut microbiome. *OMICS*, *22*(4), 248-254. https://doi.org/10.1089/omi.2018.0013
- Porcari S, Mullish BH, Asnicar F, Ng SC, Zhao L, Hansen R, O'Toole PW, Raes J, Hold G, Putignani L, Hvas CL, Nieuwdorp M, Sokol H, Ianiro G, Cammarota G (2025). International consensus statement on microbiome testing in clinical practice. *The Lancet Gastroenterology & Hepatology*, *10*(2), 154-167. https://doi.org/10.1016/S2468-1253(24)00311-X














